ALHYG — Hybrigenics SA Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual income statement for Hybrigenics SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2017 December 31st	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	FAS	FAS	FAS	FAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	0	0.077	0.235	-0	0
Cost of Revenue
Gross Profit	0	0.046	0.234	—	—
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	7.38	7.76	0.86	0.362	0.489
Operating Profit	-7.38	-7.69	-0.625	-0.363	-0.489
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-7.29	-7.88	-0.796	-0.327	-0.069
Provision for Income Taxes
Net Income After Taxes	-7.29	-7.53	-0.736	-0.327	-0.069
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	-7.96	-7.53	-0.736	-0.327	-0.069
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-7.96	-7.53	-0.736	-0.327	-0.069
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.156	-0.16	-0.005	-0.001	0.001
Dividends per Share